Stock Analiz

C4 Therapeutics, Inc. (CCCC) stock forecast and price target

Price $2.76 · data as of November 13, 2026

12-month price target

Average target$12.50
Upside / downside+352.9%
Analysts8
ConsensusStrong buy
Low $6.00Average $12.50High $30.00

Gold marker: average target · white marker: today’s price ($2.76)

Analyst ratings

Strong buy 2Buy 7Hold 0Sell 0Strong sell 0

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$-0.74+34.9%$27M
Next fiscal year
ends December 31, 2027
$-0.87−17.1%$24M
Next quarter
ends December 31, 2026
$-0.20−10.0%$6M
Quarter after
ends March 31, 2027
$-0.26−30.0%$5M

Consensus of the analysts covering C4 Therapeutics, updated daily. In the last 30 days 1 estimates were raised and 0 lowered.

Frequently asked questions

What is the C4 Therapeutics stock price target?

The average 12-month target from 8 analysts is $12.50, 352.9% above the current price of $2.76 Targets range from $6.00 to $30.00.

Is C4 Therapeutics a buy according to analysts?

The consensus rating is “Strong buy” (2 strong buy, 7 buy). Ratings are opinions, not guarantees; this is not investment advice.

How much is C4 Therapeutics expected to earn?

Analysts expect EPS of $-0.74 for the fiscal year ending December 31, 2026 and $-0.87 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.